1. LncRNA TP73-AS1 Exacerbates the Non-Small-Cell Lung Cancer (NSCLC) Process via Regulating miR-125a-3p-Mediated ACTN4
   Yueyang Tong et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
2. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
   Maria Konoshenko et al, 2022, International Journal of Molecular Sciences CrossRef
3. The role of plasma exosomal lnc-SNAPC5-3:4 in monitoring the efficacy of anlotinib in the treatment of advanced non-small cell lung cancer
   Chun Liu et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
4. circHUWE1 Exerts an Oncogenic Role in Inducing DDP-Resistant NSCLC Progression Depending on the Regulation of miR-34a-5p/TNFAIP8
   Xueliang Yang et al, 2021, International Journal of Genomics CrossRef
5. Potential miRNA biomarkers for the diagnosis and prognosis of esophageal cancer detected by a novel absolute quantitative RT-qPCR method
   Zhiyuan Lin et al, 2020, Scientific Reports CrossRef
6. TRIM29 in Cutaneous Squamous Cell Carcinoma
   Che-Yuan Hsu et al, 2021, Frontiers in Medicine CrossRef
7. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
   Pía Loren et al, 2022, Frontiers in Pharmacology CrossRef
8. Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50
   Min Wu et al, 2024, Current Cancer Drug Targets CrossRef